Korro Bio, Inc. (KRRO) — Cash Flow-to-Debt Ratio
Korro Bio, Inc. (KRRO) has a Cash Flow-to-Debt Ratio of -0.25x as of March 2026, meaning its operating cash flow of $-16.07 Million could theoretically repay 0% of its total liabilities ($63.99 Million) in one year. See free cash flow generation of Korro Bio, Inc. to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Korro Bio, Inc. Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Korro Bio, Inc. across 9 annual periods. Also explore Korro Bio, Inc. (KRRO) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Korro Bio, Inc. (2017–2025)
Year-by-year debt coverage analysis for Korro Bio, Inc.. For market capitalisation and broader financial context, see market value of Korro Bio, Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.27x | $-78.56 Million | $62.07 Million | ▼ -38.7% |
| 2024 | -0.91x | $-60.07 Million | $65.83 Million | ▲ +29.8% |
| 2023 | -1.30x | $-67.28 Million | $51.75 Million | ▼ -318.7% |
| 2022 | -0.31x | $-53.65 Million | $172.77 Million | ▲ +47.2% |
| 2021 | -0.59x | $-32.09 Million | $54.53 Million | ▲ +5.9% |
| 2020 | -0.63x | $-45.19 Million | $72.23 Million | ▼ -202.1% |
| 2019 | 0.61x | $34.22 Million | $55.86 Million | ▲ +420.4% |
| 2018 | -0.19x | $-17.02 Million | $89.06 Million | ▲ +35.3% |
| 2017 | -0.30x | $-14.61 Million | $49.43 Million | — |